SARASOTA, Fla.--(BUSINESS WIRE)--Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, announced today that the company has begun research and development activities on a new cutting-edge oral delivery system for nutraceuticals including medical marijuana (MMJ).
Earlier this month, NTRR hired Dr. Richard C. Kaufman to spearhead this new research and development project as well as others in the $42 billion nutraceuticals industry. The company is close to finalizing a joint venture agreement with Second Wave Ventures, LLC, a cutting-edge developer of cannabinoid products infused with healthy nutrients, in order to pioneer new methods of smokeless THC and CBD delivery.
Cannabinoids found in medical marijuana, such as the substances THC and CBD, have demonstrated several therapeutic benefits in a number of case studies. Recent pre-clinical trials conducted by the FDA suggest that THC-rich cannabis can significantly reduce the onset of neuropathy, and CBD has been found to provide relief from chronic pain due to muscle spasticity, muscle convulsions and inflammation—a type of pain often experienced by patients who suffer from Multiple Sclerosis, Fibromyalgia and Epilepsy.
Through Cannabis Technologies, Inc., NTRR is working to help introduce the next wave of healthier, more efficient systems to the ever-growing $1.7 billion MMJ market. By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Medbox, Inc. (OTCBB: MDBX), Medical Marijuana Inc. (OTCBB: MJNA) and Fusion Pharm (OTCBB: FSPM) to deliver technological advancements in the processing and use of cannabis in approved markets.
For more information on NTRR’s initiatives, please visit www.neutracorp.com.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.